Current NeuropharmacologyCurrent NeuropharmacologyCurrent Neuropharmacology1570-159X1875-6190Bentham Science64451910.2174/1570159X2214240709123555NeurologyResearch ArticleMeet the Editorial Board MemberCalkinsDavidinfo@benthamscience.netDepartment of Ophthalmology and Visual Sciences,, Vanderbilt University Medical Center1507202422142271227107012025Copyright ©; 2024, Bentham Science Publishers2024Bentham Science Publishershttps://journals.eco-vector.com/1570-159X/article/view/644519[Wareham, L.K.; Liddelow, S.A.; Temple, S.; Benowitz, L.I.; Di Polo, A.; Wellington, C.; Goldberg, J.L.; He, Z.; Duan, X.; Bu, G.; Davis, A.A.; Shekhar, K.; Torre, A.; Chan, D.C.; Canto-Soler, M.V.; Flanagan, J.G.; Subramanian, P.; Rossi, S.; Brunner, T.; Bovenkamp, D.E.; Calkins, D.J. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol. Neurodegener., 2022, 17(1), 23.][Calkins, D.J. Adaptive responses to neurodegenerative stress in glaucoma. Prog. Retin. Eye Res., 2021, 84, 100953.][Baratta, R.O.; Schlumpf, E.; Buono, B.J.D.; DeLorey, S.; Calkins, D.J. Corneal collagen as a potential therapeutic target in dry eye disease. Surv. Ophthalmol., 2022, 67(1), 60-67.][Lambert, W.S.; Carlson, B.J.; Ghose, P.; Vest, V.D.; Yao, V.; Calkins, D.J. Towards a microbead occlusion model of glaucoma for a non-human primate. Sci. Rep., 2019, 9(1), 11572.][Risner, M.L.; Pasini, S.; McGrady, N.R.; Calkins, D.J. Bax contributes to retinal ganglion cell dendritic degeneration during glaucoma. Mol. Neurobiol., 2022, 59(3), 1366-1380.][Taiel, M.; Sahel, J.A.; Calkins, D.J. Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks. Mol. Ther., 2023, 31(7), 2005-2013.][McGrady, N.R.; Boal, A.M.; Risner, M.L.; Cooper, M.L.; Pasini, S.; Lambert, W.S.; D’Alessandro, K.B.; Yao, V.; Risner, M.L.; Calkins, D.J. Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress. Proc. Natl. Acad. Sci. U.S.A, 2020, 117(31), 18810-18821.]